MSc, Operational Research and Applied Statistics
University of Salford, UK
BSc, Management Science with Economics (first-class honors)
University of Northampton, UK
Evelina Zimovetz, MSc, is a Director in the Market Access and Outcomes Strategy group at RTI HS. She has more than 11 years of experience conducting health economics and outcomes research. Ms. Zimovetz has developed cost-effectiveness, cost-utility, and budget-impact models, contributed to the development of mixed-treatment comparison meta-analyses, pricing and reimbursement strategies, global value dossiers, and objection handling materials. She has extensive experience in conducting both clinical and economic systematic reviews to HTA standards. Ms. Zimovetz has led health technology assessment submissions for NICE and SMC which incorporate economic modelling, systematic reviews, and meta-analyses. She has also led numerous expert advisory boards, blending her technical skills in health economics with her experience conducting market access projects. Her experience includes the therapeutic areas of attention-deficit/hyperactivity disorder; depression/anxiety; multiple sclerosis; ulcerative colitis and Crohn’s disease; diabetes; oncology (melanoma, soft tissue carcinoma, breast, and non-small cell lung cancer); rheumatoid arthritis; osteoporosis; neuropathic pain; allergic rhinitis; and rare diseases (hypoparathyroidism, acromegaly, and haemophilia). Ms. Zimovetz’s work has led to articles in publications such as European Journal of Health Economics, Current Medical Research and Opinion, and CNS Drugs, as well as presentations at conferences such as the International Society for Pharmacoeconomics and Outcomes (ISPOR) and the European Congress of Psychiatry (EPA).